Ono Pharmaceutical Co. Lt... (OPHLF)

PNK: OPHLF · Real-Time Price · USD

12.75

0.00 (0.00%)

At close: Apr 29, 2025, 2:09 PM

Ono Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Revenue	502.67B	447.19B	361.36B	309.28B	292.42B	288.63B	261.84B	244.8B	160.28B
Cost of Revenue	127.13B	110.06B	93.51B	85.57B	79.06B	83.83B	65.39B	65.52B	41.52B
Gross Profit	375.55B	337.13B	267.85B	223.71B	213.36B	204.81B	196.44B	179.27B	118.76B
Operating Income	163.1B	141.96B	103.19B	98.33B	77.49B	62.01B	60.68B	72.28B	30.51B
Interest Income	4.03B	2.48B	2.71B	2.69B	3.05B	3.28B	3.28B	3.06B	3.09B
Pretax Income	163.73B	143.53B	105.03B	100.89B	79.7B	65.14B	63.92B	74.54B	33.27B
Net Income	127.98B	112.72B	80.52B	75.42B	59.7B	51.54B	50.28B	55.79B	24.98B
Selling & General & Admin	97.39B	89.49B	77.06B	69.23B	67.68B	70.03B	68.06B	62.05B	43.98B
Research & Development	112.38B	95.34B	75.88B	62.38B	66.5B	70.01B	68.82B	57.51B	43.37B
Other Expenses	2.68B	n/a	11.72B	-6.23B	1.69B	2.75B	-1.12B	-12.57B	904M
Operating Expenses	212.44B	195.16B	164.65B	125.38B	135.87B	142.79B	135.76B	106.99B	88.25B
Interest Expense	229M	913M	874M	137M	845M	150M	36M	260M	291M
Selling & Marketing Expenses	24.02B	17.84B	11.5B	6.9B	5.78B	4.72B	3.71B	2.88B	1.29B
Cost & Expenses	339.57B	305.22B	258.17B	210.95B	214.93B	226.62B	201.15B	172.51B	129.78B
Income Tax Expense	35.69B	30.62B	24.34B	25.39B	19.81B	13.46B	13.53B	18.5B	8.08B
Shares Outstanding (Basic)	480.02M	488.3M	496.46M	499.14M	503.98M	514.12M	518.39M	530.02M	530.03M
Shares Outstanding (Diluted)	480.09M	488.35M	496.53M	499.2M	504.04M	514.17M	518.43M	530.04M	530.04M
EPS (Basic)	266.61	230.85	162.19	151.11	118.47	100.25	97.00	105.27	47.13
EPS (Diluted)	266.60	230.79	162.16	151.09	118.45	100.24	96.99	105.26	47.13
EBITDA	178.44B	167.5B	128.54B	114.54B	91.92B	74.2B	67.39B	83.92B	36.89B
EBIT	163.96B	144.44B	105.9B	101.03B	80.54B	65.29B	63.96B	74.8B	33.56B
Depreciation & Amortization	18.14B	17.45B	17.72B	15.82B	14.21B	10.62B	9.21B	7.82B	6.53B